LB

Gap Analysis Memorandum: Clinical Trial Protocol vs. FDA Regulatory Requirements for IND Submission

Healthcare & Life SciencesFDA regulatoryclinical trialsIND applicationgap analysis21 CFR Part 312pharmaceutical compliance

Instructions

Review the attached clinical trial protocol against the FDA meeting minutes, regulatory checklist, engagement letter, and internal concerns email; produce a gap analysis memo with severity ratings and remediation recommendations. Output: `gap-analysis-memorandum.docx`.

Work type: Analyze — Read materials, reach a reasoned conclusion, produce a memo or analysis.

Deliverables (1)

  • gap-analysis-memorandum.docx

Reference documents (5)

  • DOCX
    engagement-letter-scope.docx
    46.8 KB
    Open
  • DOCX
    fda-pre-ind-meeting-minutes.docx
    55.7 KB
    Open
  • XLSX
    fda-regulatory-checklist.xlsx
    31.3 KB
  • EML
    internal-email-regulatory-concerns.eml
    11.1 KB
  • DOCX
    protocol-ptx4820-201-v3.docx
    89.5 KB
    Open

Preview renders .docx and .pdf in-page via SuperDoc; bytes are fetched on demand from the pinned upstream harvey-labs commit. Open takes you to GitHub for any file type.

Rubric (38)

Each criterion is judged independently as pass or fail. The task scores 1.0 only if every criterion passes.

38 of 38 criteria